# BrainsWay Ltd. share price today (BrainsWay Ltd., BWAY)

> BrainsWay Ltd.'s results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 5% of past readings. BWAY · Healthcare · Medical Devices · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/bway

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $11.15 (+32.3% in a year)
- P/E: 51.6× (lower than 95% of the last 1 year)
- Revenue (Jun 2026): $17.1 M (+35.4% on a year ago)
- Profit (Jun 2026): $2.7 M (+33.7% on a year ago)
- Operating margin: 14.0% (+9.4 points on a year ago)
- ROE: 10%, FY25

The main question: yearly earnings per share moved +229.1% while the share price moved +32.3%. ## What is the BrainsWay Ltd. share price today? BrainsWay Ltd.'s share price was $11.15 at the close on 3 November 2026. It has been moving sideways for 7 weeks. That is 19.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between $7 and $17, and at that close it sat 38% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 12 weeks running. Over the last 7.5 years the share price moved +98% while the S&P 500 moved +160%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 14 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does BrainsWay Ltd. pay? BrainsWay Ltd. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is BrainsWay Ltd. on? BrainsWay Ltd. is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is BrainsWay Ltd. profitable? BrainsWay Ltd. earned $2.7 M of net profit in the Jun 2026 quarter, +33.7% on the same quarter a year earlier. That is the 7th quarter in a row of profit growth. Full-year FY25 profit was $7.6 M. That is 15.8% of the quarter's revenue. The same quarter a year earlier earned $2.0 M. 1 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $7.6 M (+159.3% on the year before). Why profit moved: revenue changed +35.4% on a year earlier and the margin moved +9.4 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +90.7% and revenue +31.5%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does BrainsWay Ltd. make, and is it growing? BrainsWay Ltd. reported $17.1 M of revenue in the Jun 2026 quarter, +35.4% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 15.2% a year on average. The last full year, FY25, came in at $52.2 M. The last four reported quarters add to $60.7 M. FY25 revenue was $52.2 M, +27.3% on the year before. Recent pace: the last four quarters grew +31.5% on average, against 15.2% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +31.7%, against +29.1% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +76.7%, against +294.1% a year (rolling over). ## How much of every $100 of sales does BrainsWay Ltd. keep? BrainsWay Ltd.'s operating margin was 14.0% in the Jun 2026 quarter, 9.4 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between −46.7% and 8.3%. The latest quarter is above every full year in that period. Across 5 years it has been between −46.7% and 8.3%, and FY25's 8.3% is the highest of them. Why the margin moved: operating margin changed +9.4 percentage points on the year while gross margin changed −0.6 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead. ## Is BrainsWay Ltd.'s profit turning into cash? Over the last 2 years, 265% of BrainsWay Ltd.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $17.5 M of operating cash against $7.6 M of profit. After $2.3 M of spending on assets, $15.1 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does BrainsWay Ltd.'s cash go? BrainsWay Ltd. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $8.5 M on assets over the last 3 years. Averaged over those years that is 5.4% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $8.5 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is BrainsWay Ltd.'s P/E ratio, and how does it compare with its own history? BrainsWay Ltd.'s P/E is 51.6×, near the low end of its own history: it has been lower only 5% of the time. Its usual P/E (the middle reading) is 69.4×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks. Why the multiple is where it is: over the past year earnings per share moved +229.1% while the price moved +32.3%. Earnings did better than the price, which pulled the multiple down within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the BrainsWay Ltd. business getting better or worse? BrainsWay Ltd.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does BrainsWay Ltd. earn on its capital? BrainsWay Ltd. earned a ROE of 10% in FY25. That is up from a low of −29% in FY22. Its return on capital used (ROIC) is left out: on sales this small it reads −1,929%, a number that says nothing useful about the business. It comes from a 14.5% net margin and 0.46× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 14.5% net margin × 0.46× asset turnover × 1.55× leverage (assets divided by equity) ≈ 10.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. ## Does BrainsWay Ltd. have too much debt? BrainsWay Ltd. has total debt of $7.1 M against shareholder equity of $79.2 M as of Jun 2026, so its debt is 0.09× its equity, which is very little. Year by year, that ratio went from 0.01 in FY21 to 0.09 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the BrainsWay Ltd. shareholding pattern? We have no ownership or short-position figures for BrainsWay Ltd., so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 2.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is BrainsWay Ltd. from balance-sheet trouble? For BrainsWay Ltd., the Z-score is 6.15. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 6.15 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does BrainsWay Ltd. rank in its industry? There is no score against its industry: BrainsWay Ltd. is not among the largest members shown in this industry comparison for Medical Devices. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is BrainsWay Ltd. compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to BrainsWay Ltd. in size? BrainsWay Ltd. is the 58th largest of 75 Medical Devices companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Cerus Corporation, Senseonics Holdings, Inc. and SS Innovations International, Inc. Just below it: 908 Devices Inc., NeuroPace, Inc. and Viemed Healthcare, Inc. ### Medical Devices companies close in size

1. [Cerus Corporation](https://www.sectoralpha.in/us/stocks/cers) $472 million
2. [Senseonics Holdings, Inc.](https://www.sectoralpha.in/us/stocks/sens) $468 million
3. [SS Innovations International, Inc.](https://www.sectoralpha.in/us/stocks/ssii) $467 million
4. BrainsWay Ltd. $448 million
5. [908 Devices Inc.](https://www.sectoralpha.in/us/stocks/mass) $441 million
6. [NeuroPace, Inc.](https://www.sectoralpha.in/us/stocks/npce) $423 million
7. [Viemed Healthcare, Inc.](https://www.sectoralpha.in/us/stocks/vmd) $360 million

[All 75 Medical Devices companies, largest first](https://www.sectoralpha.in/us/sectors/medical-devices#all-companies)

### Companies close in size in other industries

1. [Greenlight Capital Re, Ltd.](https://www.sectoralpha.in/us/stocks/glre) $479 million · Insurance - Reinsurance
2. [Wabash National Corporation](https://www.sectoralpha.in/us/stocks/wnc) $478 million · Farm & Heavy Construction Machinery
3. BrainsWay Ltd. $478 million
4. [Home Bancorp, Inc.](https://www.sectoralpha.in/us/stocks/hbcp) $477 million · Banks - Regional
5. [Costamare Bulkers Holdings Limited](https://www.sectoralpha.in/us/stocks/cmdb) $477 million · Marine Shipping

## What else do people ask about BrainsWay Ltd.? ### What were BrainsWay Ltd. Ltd.'s latest quarterly results? BrainsWay Ltd. reported revenue of $17.1 M and net profit of $2.7 M for the Jun 2026 quarter. Revenue rose 35.4% and profit rose 33.7% compared with a year earlier. Earnings per share were $0.07. The operating margin was 14.0%, 9.4 percentage points higher than a year earlier (as of 3 November 2026). ### What is BrainsWay Ltd. Ltd.'s market cap? BrainsWay Ltd.'s market capitalisation is $448 M at a stock price of $11.15. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is BrainsWay Ltd. Ltd. performing? BrainsWay Ltd.'s share price has been moving sideways for 7 weeks. In its latest quarter, revenue rose 35.4% and profit rose 33.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 12 weeks running (as of 3 November 2026). ### Will BrainsWay Ltd. Ltd.'s stock price go up? This page does not forecast BrainsWay Ltd.'s stock price. What it shows instead: the stock price is $11.15, and it has been moving sideways for 7 weeks. Its P/E of 51.6× is higher than 5% of its own last 2 years (as of 3 November 2026). ### Is BrainsWay Ltd. Ltd.'s profit real cash? Yes, over the last 2 years, 265% of BrainsWay Ltd.'s reported profit came in as cash from operations. The latest year was lower at 231%, so the trend is worth watching. In FY25, operating cash was $17.5 M against reported profit of $7.6 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is BrainsWay Ltd. Ltd. in its business cycle? BrainsWay Ltd.'s FY25 operating margin was 8.3%, against a 5-year range of −46.7% to 8.3%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 14.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the BrainsWay Ltd. Ltd. story? The main question: yearly earnings per share moved +229.1% while the share price moved +32.3%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is BrainsWay Ltd. Ltd. a stock worth studying right now? What the numbers show: BrainsWay Ltd.'s results are improving, while its P/E is near the low end of its own history over 1 year, higher than only 5% of past readings. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.